• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺偶发癌:延迟治疗的选择

Incidental carcinoma of the prostate: selection for deferred treatment.

作者信息

Beynon L L, Busuttil A, Newsam J E, Chisholm G D

出版信息

Br J Urol. 1983 Dec;55(6):733-6. doi: 10.1111/j.1464-410x.1983.tb03415.x.

DOI:10.1111/j.1464-410x.1983.tb03415.x
PMID:6652446
Abstract

Fifty-one of 212 consecutive patients with prostatic cancer presented with incidentally diagnosed (TO) cancer. The average age at presentation was 73 years and follow-up ranged from 1 to 62 months. Deferred treatment was selected in 39 cases, 10 of which progressed. Of 15 deaths only 3 were related to prostate cancer and these were patients who had presented with metastases. Histological grading by the Gleason system demonstrated a significant correlation with metastatic stage at presentation and tumour bulk, but not with age or progression in deferred treatment cases. It is concluded that there is a need to subdivide patients presenting with incidental carcinoma, that tumour bulk correlates with histological grade and that future treatment protocols for TO disease should stratify for histological grade.

摘要

在212例连续性前列腺癌患者中,有51例为偶然诊断出的(T0期)癌症。确诊时的平均年龄为73岁,随访时间为1至62个月。39例患者选择了延迟治疗,其中10例病情进展。15例死亡病例中,只有3例与前列腺癌相关,且这些患者均已出现转移。根据Gleason系统进行的组织学分级显示,其与确诊时的转移分期和肿瘤体积显著相关,但与年龄或延迟治疗病例的病情进展无关。结论是,有必要对偶然癌患者进行细分,肿瘤体积与组织学分级相关,未来针对T0期疾病的治疗方案应根据组织学分级进行分层。

相似文献

1
Incidental carcinoma of the prostate: selection for deferred treatment.前列腺偶发癌:延迟治疗的选择
Br J Urol. 1983 Dec;55(6):733-6. doi: 10.1111/j.1464-410x.1983.tb03415.x.
2
Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.冰岛前列腺腺癌:一项基于人群的研究,涉及1983年至1987年间确诊的男性患者的分期、Gleason分级、治疗及长期生存情况。
Scand J Urol Nephrol. 2006;40(4):265-71. doi: 10.1080/00365590600750110.
3
Age, and size and grade of tumour predict prognosis in incidentally diagnosed carcinoma of the prostate.年龄、肿瘤大小和分级可预测偶然诊断的前列腺癌的预后。
Br J Urol. 1988 Dec;62(6):576-80. doi: 10.1111/j.1464-410x.1988.tb04429.x.
4
Deferred treatment of low grade stage T3 prostate cancer without distant metastases.对无远处转移的低级别T3期前列腺癌进行延迟治疗。
J Urol. 1993 Feb;149(2):326-8; discussion 328-9. doi: 10.1016/s0022-5347(17)36071-8.
5
Incidental carcinoma of the prostate: treatment selection by second-look TURP.前列腺偶发癌:经二次经尿道前列腺切除术进行治疗选择
Br J Urol. 1984 Dec;56(6):682-6. doi: 10.1111/j.1464-410x.1984.tb06146.x.
6
Clinico-pathologic characterisation of metastatic prostate cancer in the Radiotherapy and Oncology Department, Ahmadu Bello University Teaching Hospital, Zaria-Nigeria: 2006-2009.2006 - 2009年尼日利亚扎里亚阿哈穆杜·贝洛大学教学医院放疗与肿瘤科转移性前列腺癌的临床病理特征
Niger Postgrad Med J. 2013 Mar;20(1):45-51.
7
Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council Trial. The Medical Research Council Prostate Cancer Working Party Investigators Group.晚期前列腺癌的即刻治疗与延迟治疗:医学研究委员会试验的初步结果。医学研究委员会前列腺癌工作组研究人员小组
Br J Urol. 1997 Feb;79(2):235-46. doi: 10.1046/j.1464-410x.1997.d01-6840.x.
8
[Onset of and survival in adenocarcinoma of the prostate. Analysis of 48 consecutive cases studied over 10 years].[前列腺腺癌的发病及生存情况。对连续48例患者进行10年研究的分析]
Arch Esp Urol. 1989;42 Suppl 2:117-23.
9
Deferred treatment in clinically localised prostatic carcinoma.临床局限性前列腺癌的延迟治疗
Br J Urol. 1992 Feb;69(2):183-7. doi: 10.1111/j.1464-410x.1992.tb15493.x.
10
De-differentiation with time in prostate cancer and the influence of treatment on the course of the disease.前列腺癌中细胞去分化随时间的变化以及治疗对疾病进程的影响。
Br J Urol. 1990 Mar;65(3):271-4. doi: 10.1111/j.1464-410x.1990.tb14725.x.

引用本文的文献

1
Epidermal growth factor receptors in human prostate cancer: correlation with histological differentiation of the tumour.人前列腺癌中的表皮生长因子受体:与肿瘤组织学分化的相关性
Br J Cancer. 1989 Jul;60(1):41-4. doi: 10.1038/bjc.1989.216.
2
Flow cytometric analysis of cellular DNA in human prostate cancer: relationship to 5 alpha-reductase activity of the tissue.人前列腺癌中细胞DNA的流式细胞术分析:与组织5α-还原酶活性的关系
Urol Res. 1989;17(4):239-43. doi: 10.1007/BF00262601.
3
Incidental versus manifest prostatic carcinoma.
Int Urol Nephrol. 1987;19(2):175-8. doi: 10.1007/BF02550470.